Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongping Yang

Showing results (301-310 of 324) with videos related to

Pageof 33
Sort By:
JHEP Reports : Innovation in Hepatology|July 17, 2023
Use of albumin infusion for cirrhosis-related complications: An international position statementZhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Therapeutic Advances in Gastroenterology|May 23, 2022
Practice guidance for the use of terlipressin for liver cirrhosis-related complicationsXingshun Qi, Zhaohui Bai, Qiang Zhu, et al.
Cell Reports|December 15, 2024
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodiesEvan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.
Science (New York, N.Y.)|August 13, 2011
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencingXueling Wu, Tongqing Zhou, Jiang Zhu, et al.
Immunity|August 6, 2013
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodiesTongqing Zhou, Jiang Zhu, Xueling Wu, et al.
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Immunity|March 18, 2018
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV EnvelopeTongqing Zhou, Anqi Zheng, Ulrich Baxa, et al.
Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Pageof 33

Showing results (301-310 of 324) with videos related to

Sort By:
Pageof 33
JHEP Reports : Innovation in Hepatology|July 17, 2023
Use of albumin infusion for cirrhosis-related complications: An international position statementZhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Therapeutic Advances in Gastroenterology|May 23, 2022
Practice guidance for the use of terlipressin for liver cirrhosis-related complicationsXingshun Qi, Zhaohui Bai, Qiang Zhu, et al.
Cell Reports|December 15, 2024
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodiesEvan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.
Science (New York, N.Y.)|August 13, 2011
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencingXueling Wu, Tongqing Zhou, Jiang Zhu, et al.
Immunity|August 6, 2013
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodiesTongqing Zhou, Jiang Zhu, Xueling Wu, et al.
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Immunity|March 18, 2018
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV EnvelopeTongqing Zhou, Anqi Zheng, Ulrich Baxa, et al.
Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Pageof 33